"Psychotic Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Descriptor ID |
D011618
|
| MeSH Number(s) |
F03.700.675
|
| Concept/Terms |
Psychotic Disorders- Psychotic Disorders
- Disorder, Psychotic
- Disorders, Psychotic
- Psychotic Disorder
- Psychosis
- Psychoses
Schizoaffective Disorder- Schizoaffective Disorder
- Disorder, Schizoaffective
- Disorders, Schizoaffective
- Schizoaffective Disorders
Schizophreniform Disorders- Schizophreniform Disorders
- Disorder, Schizophreniform
- Disorders, Schizophreniform
- Schizophreniform Disorder
Psychosis, Brief Reactive- Psychosis, Brief Reactive
- Brief Reactive Psychoses
- Brief Reactive Psychosis
- Psychoses, Brief Reactive
- Reactive Psychoses, Brief
- Reactive Psychosis, Brief
|
Below are MeSH descriptors whose meaning is more general than "Psychotic Disorders".
Below are MeSH descriptors whose meaning is more specific than "Psychotic Disorders".
This graph shows the total number of publications written about "Psychotic Disorders" by people in this website by year, and whether "Psychotic Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2005 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 6 | 0 | 6 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 2 | 5 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psychotic Disorders" by people in Profiles.
-
Anglin DM, Ereshefsky S, Klaunig MJ, Bridgwater MA, Niendam TA, Ellman LM, DeVylder J, Thayer G, Bolden K, Musket CW, Grattan RE, Lincoln SH, Schiffman J, Lipner E, Bachman P, Corcoran CM, Mota NB, van der Ven E. From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States. Am J Psychiatry. 2021 07; 178(7):599-610.
-
Nikogosyan G, Orias D, Goebert D, Takeshita J, Wang M. Acute Aripiprazole-Associated Liver Injury. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):344-346.
-
Oh HY, Koyanagi A, DeVylder JE, Link B. Urban upbringing and psychotic experiences in the United States: A racial and geographic comparison. Psychiatry Res. 2020 11; 293:113372.
-
Anglin DM, Galea S, Bachman P. Going Upstream to Advance Psychosis Prevention and Improve Public Health. JAMA Psychiatry. 2020 07 01; 77(7):665-666.
-
Dou Y, Blaine Crowley T, Gallagher S, Bailey A, McGinn D, Zackai E, Gur RE, McGinn DM, Sullivan KE. Increased T-cell counts in patients with 22q11.2 deletion syndrome who have anxiety. Am J Med Genet A. 2020 07; 182(7):1815-1818.
-
Anglin DM. Advancing the study of local ethnic density and psychosis. Lancet Psychiatry. 2020 04; 7(4):293-294.
-
Desai R, Patel K, Dave H, Shah K, DeWitt N, Fong HK, Varma Y, Varma K, Mansuri Z, Sachdeva R, Khanna A, Kumar G. Nationwide Frequency, Sequential Trends, and Impact of Co-morbid Mental Health Disorders on Hospitalizations, Outcomes, and Healthcare Resource Utilization in Adult Congenital Heart Disease. Am J Cardiol. 2020 04 15; 125(8):1256-1262.
-
Hanna B, Desai R, Parekh T, Guirguis E, Kumar G, Sachdeva R. Psychiatric disorders in the U.S. transgender population. Ann Epidemiol. 2019 11; 39:1-7.e1.
-
Cohen AN, Pedersen ER, Glynn SM, Hamilton AB, McNagny KP, Reist C, Chemerinski E, Young AS. Preferences for family involvement among veterans in treatment for schizophrenia. Psychiatr Rehabil J. 2019 Sep; 42(3):210-219.
-
Da Silva T, Hafizi S, Rusjan PM, Houle S, Wilson AA, Prce I, Sailasuta N, Mizrahi R. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study. J Psychiatry Neurosci. 2019 03 01; 44(2):111-119.